For the industry
This project will sustainably produce human (allogeneic) somatic stem cell materials that can be used in the manufacture of regenerative medical products in Japan.
The purpose is to establish a supply system that can provide a stable quality of cells.
In addition to Keio University Hospital, four medical institutions and companies will play a central role in this project.
Keio University Hospital has a network that will be used to provide cell materials that meet the needs of companies.
By building a system that enables a stable supply of cells while maintaining quality, we will inform the general public of the social significance of our project, and contribute to the development of the regenerative medicine industry in Japan